pRIFLE Pediatric AKI
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۰۰ • واحد: %
حداقل ۱ — حداکثر ۲۰۰ • واحد: mL/min/1.73m²
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- No AKI0–0
- Risk1–1
- Injury2–2
- Failure3–3
The pRIFLE Pediatric AKI calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include egfr decrease pct. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
pRIFLE pediatric acute kidney injury classification (Akcan-Arikan 2007): Risk (eGFR ↓≥25% or UO <0.5 mL/kg/h × 8 h), Injury (eGFR ↓≥50% or UO <0.5 × 16 h), Failure (eGFR ↓≥75% or eGFR <35 or UO <0.3 × 24 h or anuria × 12 h), Loss (persistent failure >4 weeks), End-stage (>3 months). Class = worst of eGFR and urine-output criteria.
Clinical Indication
The pRIFLE Pediatric AKI is indicated for bedside clinical practice to support pRIFLE pediatric acute kidney injury classification (Akcan-Arikan 2007): Risk (eGFR ↓≥25% or UO <0.5 mL/kg/h × 8 h), Injury (eGFR ↓≥50% or UO <0.5 × 16 h), Failure (eGFR ↓≥75% or eGFR <35 or UO <0.3 × 24 h or anuria × 12 h), Loss (persistent failure >4 weeks), End-stage (>3 months). Class = worst of eGFR and urine-output criteria.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.
Limitations & Contraindications
Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.
Clinical Pearls & Action Plan
Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice.
Class = worst(eGFR criterion, UO criterion)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| egfr_decrease_pct | float | Yes | eGFR percent decrease from baseline(%) |
| egfr_current | float | No | Current eGFR (for the <35 Failure rule)(mL/min/1.73m²) |
| uo_category | string | No | Worst urine-output category observed |
| persistence | string | No | Persistent failure duration |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | No AKI | No AKI |
| 1–1 | Risk | Risk |
| 2–2 | Injury | Injury |
| 3–3 | Failure | Failure |
| 4–4 | Loss | Loss |
| 5–5 | End-stage | End-stage |
Evidence-Based References (EBM)
- Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028-1035.